Table 3. Location of the cavitary lesions, microbiological culture results, documented VTE presence, and WHO clinical progression scale of patients.

DVT: deep vein thrombosis; VTE: venous thromboembolism; MTB: Mycobacterium tuberculosis; BAL: bronchoalveolar lavage; DTA: deep tracheal aspirate; MSSA: methicillin-sensitive Staphylococcus aureus; MRSA: methicillin-resistant Staphylococcus aureus; sPE*: segmental pulmonary embolism; **: BAL cultures; ^^: sputum culture; RUL: right upper lobe; LUL: left upper lobe; RML: right middle lobe; RLL: right lower lobe; LLL: left lower lobe

	WHO clinical progression scale	Radiological score	Documented VTE	Culture results	Cavitary lesion detection time after PCR positivity (days)	Location of cavitary lesions	Number of cavities	Wall thickness of cavitary lesions	Longest diameter of cavitary lesions
Patient 1	5	6	Bilateral sPE*	MTB complex**	42	RLL	2	4 mm	13 mm
Patient 2	5	9	Left femoral vein DVT+bilateral sPE*	-**	23	LLL	2	5.6 mm	12 mm
Patient 3	6	12	-	Galactomannan+**	52	RUL	2	8 mm	39 mm
Patient 4	9	20	-	K. pneumonia**	56	RUL+LUL	2	3.1 mm	18 mm
Patient 5	6	15	Bilateral sPE*	MTB complex**	58	LLL	2	3.9 mm	16 mm
Patient 6	6	19	Bilateral sPE*	-**	61	RUL	1	3.4 mm	14 mm
Patient 7	10	19	-	MSSA^^	23	RML	1	5.14 mm	24 mm
Patient 8	5	20	-	-**	116	RUL	2	5.8 mm	39 mm
Patient 9	6	20	Bilateral sPE*	K. pneumoniae**	70	LLL	1	1.58 mm	47 mm
Patient 10	6	12	-	K. pneumoniae**	50	LUL	1	5.4 mm	52 mm
Patient 11	6	13	Bilateral sPE*	-^^	34	RLL+LLL	3	3.7 mm	49 mm
Patient 12	8	9	-	MRSA^^	26	LLL	1	3.2 mm	44 mm
Patient 13	5	9	-	-	82	RUL	1	7 mm	11 mm
Patient 14	5	7	-	-	32	RLL	1	6 mm	9 mm
Patient 15	5	12	-	Galactomannan+**	74	RUL+LUL	2	5.1 mm	37 mm